Skip to main content
Top
Gepubliceerd in: Quality of Life Research 7/2015

01-07-2015

The EQ-5D-5L index score is more discriminative than the EQ-5D-3L index score in diabetes patients

Auteurs: Chen-Wei Pan, Hong-Peng Sun, Xingzhi Wang, Qinghua Ma, Yong Xu, Nan Luo, Pei Wang

Gepubliceerd in: Quality of Life Research | Uitgave 7/2015

Log in om toegang te krijgen
share
DELEN

Deel dit onderdeel of sectie (kopieer de link)

  • Optie A:
    Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
  • Optie B:
    Deel de link per e-mail

Abstract

Purpose

To compare the discriminative power of the index scores of EQ-5D-5L (5L) and EQ-5D-3L (3L) in diabetes patients in China.

Methods

A consecutive sample of type 2 diabetes mellitus (T2DM) patients in the clinics self-completed the two versions of EQ-5D. The 3L index score was obtained from the Chinese 3L value set; the 5L index score was predicted from the 3L index score using an interim scoring. Relative efficiency (RE) of the 5L and 3L index scores was calculated to compare their ability in differentiating between T2DM patients with and without one of ten clinical conditions. The efficiency of the 5L and 3L health state classification systems was assessed using the Shannon index (H′) and in terms of ceiling effects.

Results

A total of 289 T2DM patients participated in this study. The 5L score was systematically lower than the 3L score for T2DM patients with and without a condition (range −0.36 to −0.06). The 5L score exhibited higher discriminative power in nine of ten conditions, with the mean RE value being 1.92. 5L had higher H′ values than 3L in all the five EQ-5D dimensions: mobility (1.14 vs. 0.70), self-care (0.44 vs. 0.33), usual activities (0.72 vs. 0.47), pain/discomfort (1.58 vs. 1.10), and anxiety/depression (1.03 vs. 0.67). The overall ceiling effects decreased from 56.7 % (3L) to 36.7 % (5L).

Conclusion

The 5L index score is more discriminative than the 3L index score in T2DM patients and therefore is preferable for use in this population.
Literatuur
1.
go back to reference Rabin, R., & de Charro, F. (2001). EQ-5D: A measure of health status from the EuroQol Group. Annals of Medicine, 33, 337–343.PubMedCrossRef Rabin, R., & de Charro, F. (2001). EQ-5D: A measure of health status from the EuroQol Group. Annals of Medicine, 33, 337–343.PubMedCrossRef
2.
3.
go back to reference Shaw, J. W., Johnson, J. A., & Coons, S. J. (2005). US valuation of the EQ-5D health states: Development and testing of the D1 valuation model. Medical Care, 45, 203–220.CrossRef Shaw, J. W., Johnson, J. A., & Coons, S. J. (2005). US valuation of the EQ-5D health states: Development and testing of the D1 valuation model. Medical Care, 45, 203–220.CrossRef
4.
go back to reference Liu, G., Wu, H., Li, M., Gao, C., & Luo, N. (2014). Chinese time trade-off values for EQ-5D health states. Value in Health, 17, 597–604.PubMedCrossRef Liu, G., Wu, H., Li, M., Gao, C., & Luo, N. (2014). Chinese time trade-off values for EQ-5D health states. Value in Health, 17, 597–604.PubMedCrossRef
5.
go back to reference Luo, N., Wang, P., Thumboo, J., Lim, Y. W., & Vrijhoef, H. J. (2014). Valuation of EQ-5D-3L health states in Singapore: Modeling of time trade-off values for 80 empirically observed health states. Pharmacoeconomics, 30(5), 495–507.CrossRef Luo, N., Wang, P., Thumboo, J., Lim, Y. W., & Vrijhoef, H. J. (2014). Valuation of EQ-5D-3L health states in Singapore: Modeling of time trade-off values for 80 empirically observed health states. Pharmacoeconomics, 30(5), 495–507.CrossRef
6.
go back to reference Tsuchiya, A., Ikeda, S., Ikegami, N., Nishimura, S., Sakai, I., Fukuda, T., et al. (2002). Estimating an EQ-5D population value set: The case of Japan. Health Economics, 11(4), 341–353.PubMedCrossRef Tsuchiya, A., Ikeda, S., Ikegami, N., Nishimura, S., Sakai, I., Fukuda, T., et al. (2002). Estimating an EQ-5D population value set: The case of Japan. Health Economics, 11(4), 341–353.PubMedCrossRef
7.
go back to reference Baida, X., Roset, M., Herdman, M., & Kind, P. (2001). A comparison of United Kingdom and Spanish general population general population time trade-off values for EQ-5D health states. Medical Decision Making, 21(1), 7–16.CrossRef Baida, X., Roset, M., Herdman, M., & Kind, P. (2001). A comparison of United Kingdom and Spanish general population general population time trade-off values for EQ-5D health states. Medical Decision Making, 21(1), 7–16.CrossRef
8.
go back to reference Luo, N., Johnson, J. A., Shaw, J. W., & Coons, S. J. (2007). A comparison of EQ-5D index scores derived from the US and UK population-based scoring functions. Medical Decision Making, 27(3), 321–326.CrossRef Luo, N., Johnson, J. A., Shaw, J. W., & Coons, S. J. (2007). A comparison of EQ-5D index scores derived from the US and UK population-based scoring functions. Medical Decision Making, 27(3), 321–326.CrossRef
9.
go back to reference Norman, R., Cronin, P., Viney, R., King, M., Street, D., & Ratcliffe, J. (2009). International comparisons in valuing EQ-5D health states: A review and analysis. Value in Health, 12(8), 1194–1200.PubMedCrossRef Norman, R., Cronin, P., Viney, R., King, M., Street, D., & Ratcliffe, J. (2009). International comparisons in valuing EQ-5D health states: A review and analysis. Value in Health, 12(8), 1194–1200.PubMedCrossRef
10.
go back to reference Janssen, M. F., Lubetkin, E. I., Sekhobo, J. P., & Pickard, A. S. (2011). The use of the EQ-5D preference-based health status measure in adults with Type 2 diabetes mellitus. Diabetic Medicine, 28, 395–413.PubMedCrossRef Janssen, M. F., Lubetkin, E. I., Sekhobo, J. P., & Pickard, A. S. (2011). The use of the EQ-5D preference-based health status measure in adults with Type 2 diabetes mellitus. Diabetic Medicine, 28, 395–413.PubMedCrossRef
11.
go back to reference Wang, H. M., Patrick, D. L., Edwards, T. C., Skalicky, A. M., Zeng, H. Y., & GU, W. W. (2012). Validation of the EQ-5D in a general population sample in urban China. Quality of Life Research, 21(1), 155–160.PubMedCrossRef Wang, H. M., Patrick, D. L., Edwards, T. C., Skalicky, A. M., Zeng, H. Y., & GU, W. W. (2012). Validation of the EQ-5D in a general population sample in urban China. Quality of Life Research, 21(1), 155–160.PubMedCrossRef
12.
go back to reference Luo, N., Cang, S. Q., Quan, H. M. J., How, C. H., & Tay, E. G. (2012). The discriminative power of the EuroQol visual analog scale is sensitive to survey language in Singapore. Health and Quality of Life Outcomes, 10, 32.PubMedCentralPubMedCrossRef Luo, N., Cang, S. Q., Quan, H. M. J., How, C. H., & Tay, E. G. (2012). The discriminative power of the EuroQol visual analog scale is sensitive to survey language in Singapore. Health and Quality of Life Outcomes, 10, 32.PubMedCentralPubMedCrossRef
13.
go back to reference Pickard, A. S., Wilke, C. T., Lin, H. W., et al. (2007). Health utilities using the EQ-5D in studies of cancer. Pharmacoeconomics, 25, 365–394.PubMedCrossRef Pickard, A. S., Wilke, C. T., Lin, H. W., et al. (2007). Health utilities using the EQ-5D in studies of cancer. Pharmacoeconomics, 25, 365–394.PubMedCrossRef
14.
go back to reference Ong, S. C., Mark, B., Aung, M. O., Li, S. C., & Lim, S. G. (2008). Health-related quality of life in chronic hepatitis B patients. Hepatology, 47(4), 1108–1117.PubMedCrossRef Ong, S. C., Mark, B., Aung, M. O., Li, S. C., & Lim, S. G. (2008). Health-related quality of life in chronic hepatitis B patients. Hepatology, 47(4), 1108–1117.PubMedCrossRef
15.
go back to reference McLernon, D. J., Dillon, J., & Donna, P. T. (2008). Health-state utilities in liver disease: A systematic review. Medical Decision Making, 28(4), 582–592.PubMedCrossRef McLernon, D. J., Dillon, J., & Donna, P. T. (2008). Health-state utilities in liver disease: A systematic review. Medical Decision Making, 28(4), 582–592.PubMedCrossRef
16.
go back to reference Macran, S., Weatherly, H., & Kind, P. (2003). Measuring population health? A comparison of three generic health status measures. Medical Care, 42, 218–231. Macran, S., Weatherly, H., & Kind, P. (2003). Measuring population health? A comparison of three generic health status measures. Medical Care, 42, 218–231.
17.
go back to reference Petrou, S., & Hockely, C. (2005). An investigation into the empirical validity of the EQ-5D and SF-6D based on hypothetical preferences in a general population. Health Economics, 14, 1169–1189.PubMedCrossRef Petrou, S., & Hockely, C. (2005). An investigation into the empirical validity of the EQ-5D and SF-6D based on hypothetical preferences in a general population. Health Economics, 14, 1169–1189.PubMedCrossRef
18.
go back to reference Myers, C., & Wilks, D. (1999). Comparison of Euroqol EQ-5D and SF-36 in patients with chronic fatigue syndrome. Quality of Life Research, 8, 9–16.PubMedCrossRef Myers, C., & Wilks, D. (1999). Comparison of Euroqol EQ-5D and SF-36 in patients with chronic fatigue syndrome. Quality of Life Research, 8, 9–16.PubMedCrossRef
19.
go back to reference Bharmal, M., & Thomas, J. I. I. I. (2006). Comparing the EQ-5D and the SF-6D descriptive systems to assess their ceiling effects in the US general population. Value in Health, 9, 262–271.PubMedCrossRef Bharmal, M., & Thomas, J. I. I. I. (2006). Comparing the EQ-5D and the SF-6D descriptive systems to assess their ceiling effects in the US general population. Value in Health, 9, 262–271.PubMedCrossRef
20.
go back to reference Wang, H., Kindig, D. A., & Mullahy, J. (2005). Variation in Chinese population health related quality of life: Results from a EuroQol study in Beijing, China. Quality of Life Research, 14, 119–132.PubMedCrossRef Wang, H., Kindig, D. A., & Mullahy, J. (2005). Variation in Chinese population health related quality of life: Results from a EuroQol study in Beijing, China. Quality of Life Research, 14, 119–132.PubMedCrossRef
21.
go back to reference Brazier, J., Roberts, J., & Tsychiya, A. (2004). A comparison of the EQ-5D and SF-6D across seven patients groups. Health Economics, 13, 873–884.PubMedCrossRef Brazier, J., Roberts, J., & Tsychiya, A. (2004). A comparison of the EQ-5D and SF-6D across seven patients groups. Health Economics, 13, 873–884.PubMedCrossRef
22.
go back to reference Bech, P., Moses, R., & Gomis, R. (2008). The effect of prandial glucose regulation with repaglinide on treatment satisfaction, wellbeing and health status in patients with pharmacotherapy naïve Type 2 diabetes: A placebo-controlled, multicentre study. Quality of Life Research, 12, 413–425.CrossRef Bech, P., Moses, R., & Gomis, R. (2008). The effect of prandial glucose regulation with repaglinide on treatment satisfaction, wellbeing and health status in patients with pharmacotherapy naïve Type 2 diabetes: A placebo-controlled, multicentre study. Quality of Life Research, 12, 413–425.CrossRef
23.
go back to reference Bagust, A., & Beale, S. (2005). Modelling EuroQol health-related utility values for diabetic complications from CODE-2 data. Health Economics, 14, 217–230.PubMedCrossRef Bagust, A., & Beale, S. (2005). Modelling EuroQol health-related utility values for diabetic complications from CODE-2 data. Health Economics, 14, 217–230.PubMedCrossRef
24.
go back to reference Morgan, C. L., McEwan, P., Morrissey, M., Peter, J. R., Poole, C., & Currie, C. J. (2006). Characterization and comparison of health-related utility in people with diabetes with various single and multiple vascular complications. Diabetic Medicine, 23, 1100–1105.PubMedCrossRef Morgan, C. L., McEwan, P., Morrissey, M., Peter, J. R., Poole, C., & Currie, C. J. (2006). Characterization and comparison of health-related utility in people with diabetes with various single and multiple vascular complications. Diabetic Medicine, 23, 1100–1105.PubMedCrossRef
26.
go back to reference van Hout, B., Janssen, M. F., Feng, Y. S., Kohlmann, T., Busschbach, J., Golicki, D., et al. (2012). Interim scoring for the EQ-5D-5L: Mapping the EQ-5D-5L to EQ-5D-3L value sets. Value in Health, 15(5), 708–715.PubMedCrossRef van Hout, B., Janssen, M. F., Feng, Y. S., Kohlmann, T., Busschbach, J., Golicki, D., et al. (2012). Interim scoring for the EQ-5D-5L: Mapping the EQ-5D-5L to EQ-5D-3L value sets. Value in Health, 15(5), 708–715.PubMedCrossRef
27.
go back to reference Jia, Y. X., Cui, F. Q., Li, L., Zhang, D. L., Zhang, G. M., Wang, F. Z., et al. (2014). Comparison between the EQ-5D-5L and the EQ-5D-3L in patients with hepatitis B. Quality of Life Research,. doi:10.1007/311136-014-0670-3.PubMed Jia, Y. X., Cui, F. Q., Li, L., Zhang, D. L., Zhang, G. M., Wang, F. Z., et al. (2014). Comparison between the EQ-5D-5L and the EQ-5D-3L in patients with hepatitis B. Quality of Life Research,. doi:10.​1007/​311136-014-0670-3.PubMed
28.
go back to reference Kim, S. H., Kim, H. J., Lee, S. I., & Jo, M. W. (2012). Comparing the psychometric properties of the EQ-5D-3L and EQ-5D-5L in cancer patients in Korea. Quality of Life Research, 21(6), 1065–1073.PubMedCrossRef Kim, S. H., Kim, H. J., Lee, S. I., & Jo, M. W. (2012). Comparing the psychometric properties of the EQ-5D-3L and EQ-5D-5L in cancer patients in Korea. Quality of Life Research, 21(6), 1065–1073.PubMedCrossRef
29.
go back to reference Pickard, A. S., De leon, M. C., Kohlmann, T., Cella, D., & Rosenbloom, S. (2007). Psychometric comparison of the standard EQ-5D to a 5 level version in cancer patients. Medical Care, 45(3), 259–263.PubMedCrossRef Pickard, A. S., De leon, M. C., Kohlmann, T., Cella, D., & Rosenbloom, S. (2007). Psychometric comparison of the standard EQ-5D to a 5 level version in cancer patients. Medical Care, 45(3), 259–263.PubMedCrossRef
30.
go back to reference Scalone, L., Ciampichini, R., Fagiuoli, S., Gardini, I., Fusco, F., Gaeta, L., et al. (2013). Comparing the performance of the standard EQ-5D 3L with the new version EQ-5D 5L in patients with chronic hepatic disease. Quality of Life Research, 22(7), 1707–1716.PubMedCrossRef Scalone, L., Ciampichini, R., Fagiuoli, S., Gardini, I., Fusco, F., Gaeta, L., et al. (2013). Comparing the performance of the standard EQ-5D 3L with the new version EQ-5D 5L in patients with chronic hepatic disease. Quality of Life Research, 22(7), 1707–1716.PubMedCrossRef
31.
go back to reference Janssen, M. F., Pickard, A. S., Golicki, D., Gudex, C., Niewada, M., Scalone, L., et al. (2013). Measurement properties of the EQ-5D-5L compared to the EQ-5D-3L across eight patient groups: A multi-country study. Quality of Life Research, 22(7), 1717–1727.PubMedCentralPubMedCrossRef Janssen, M. F., Pickard, A. S., Golicki, D., Gudex, C., Niewada, M., Scalone, L., et al. (2013). Measurement properties of the EQ-5D-5L compared to the EQ-5D-3L across eight patient groups: A multi-country study. Quality of Life Research, 22(7), 1717–1727.PubMedCentralPubMedCrossRef
32.
go back to reference Janssen, M. F., Birnie, E., Haagsma, J. A., & Bonsel, G. J. (2008). Comparing the standard EQ-5D three-level system with a five-level version. Value in Health, 11(2), 275–284.PubMedCrossRef Janssen, M. F., Birnie, E., Haagsma, J. A., & Bonsel, G. J. (2008). Comparing the standard EQ-5D three-level system with a five-level version. Value in Health, 11(2), 275–284.PubMedCrossRef
33.
go back to reference Craig, B. M., Pickard, A. S., & Lubetkin, E. I. (2014). Health problems are more common, but less severe when measured using newer EQ-5D versions. Journal of Clinical Epidemiology, 67, 93–99.PubMedCentralPubMedCrossRef Craig, B. M., Pickard, A. S., & Lubetkin, E. I. (2014). Health problems are more common, but less severe when measured using newer EQ-5D versions. Journal of Clinical Epidemiology, 67, 93–99.PubMedCentralPubMedCrossRef
34.
go back to reference Shannon, C. E., & Weaver, W. (1948). A mathematical theory of communication. Bell System Technical Journal, 27, 161–163.CrossRef Shannon, C. E., & Weaver, W. (1948). A mathematical theory of communication. Bell System Technical Journal, 27, 161–163.CrossRef
35.
go back to reference Janssen, M. F., Birnie, E., & Bonsel, G. J. (2007). Evaluating the discriminatory power of EQ-5D, HUI2 and HUI3 in a US general population survey using Shannon’s indices. Quality of Life Research, 16(5), 895–904.PubMedCentralCrossRef Janssen, M. F., Birnie, E., & Bonsel, G. J. (2007). Evaluating the discriminatory power of EQ-5D, HUI2 and HUI3 in a US general population survey using Shannon’s indices. Quality of Life Research, 16(5), 895–904.PubMedCentralCrossRef
Metagegevens
Titel
The EQ-5D-5L index score is more discriminative than the EQ-5D-3L index score in diabetes patients
Auteurs
Chen-Wei Pan
Hong-Peng Sun
Xingzhi Wang
Qinghua Ma
Yong Xu
Nan Luo
Pei Wang
Publicatiedatum
01-07-2015
Uitgeverij
Springer International Publishing
Gepubliceerd in
Quality of Life Research / Uitgave 7/2015
Print ISSN: 0962-9343
Elektronisch ISSN: 1573-2649
DOI
https://doi.org/10.1007/s11136-014-0902-6

Andere artikelen Uitgave 7/2015

Quality of Life Research 7/2015 Naar de uitgave